Biomarkers Improve Odds Of Approval, Study Finds
This article was originally published in SRA
Executive Summary
Clinical programs that used biomarkers to select patients for clinical trials of drugs had a three-fold higher likelihood of approval than ones with no selection biomarkers, an analysis of 10 years of clinical development programs has found1.